Bioavailability of ATI-1501 With Taste Test Sub Study

Summary

Appili Therapeutics Inc. is developing an oral suspension formulation of metronidazole (ATI-1501), a taste-masked reformulation of metronidazole. The purpose of this study is to compare the relative bioavailability of ATI-1501 with the Reference Listed Drug (RLD) in healthy, adult volunteers to determine that it is Bioequivalent.

Timeline

Start

2017-11-06

Primary completion

2017-12-13

Completion

2017-12-30

Drugs

Indications

No indication recorded.